For more than 30 years, physicians around the world have been deploying Ellex ophthalmic laser and ultrasound systems to achieve the highest standard of ophthalmic outcomes.
Our solutions now include iTrack™ for minimally invasive glaucoma surgery (MIGS), and Ellex 2RT™, which enables ophthalmologists to focus on the provision of proactive patient care in the delivery of retinal rejuvenation.
Every day, our technology is helping to secure optimum results — safely, effectively, accurately and consistently.
Find out more about our products…
Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.
The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.